The disclosure relates to di-aliphatic substituted PEGylated lipids and to methods of their preparation. The disclosure also relates to lipid conjugates containing di-aliphatic substituted PEGylated lipids, and to the use of di-aliphatic substituted PEGylated-lipid conjugates in drug delivery.
申请公布号
AU2012315965(A1)
申请公布日期
2014.04.03
申请号
AU20120315965
申请日期
2012.09.27
申请人
TAKEDA PHARMACEUTICAL COMPANY LIMITED;ALNYLAM PHARMACEUTICALS, INC.